BioNTech SE
Long
Updated

BNTX Analysis

365
On 24/8/2020 i posted an analysis on this stock being over valued. The min entry price of $57.
AstraZeneca starts U.S final-stage trial of covid-19 vaccine have meant that BNTX is behind the race, but that also means speculators will come in long soon.
Look for short term buying opportunities to price of $70.
DO Not hold this high growth stock, dangerous.
Note
entered at $57

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.